Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature
Abstract Background Neurologic complications as myelitis are very rare but extremely deleterious adverse effects of both immunotherapy and radiotherapy. Many recent studies have focused on the possible synergy of these two treatment modalities due to their potential to enhance each other’s immunomod...
Main Authors: | Marcela Carausu, Arnaud Beddok, Adriana Langer, Nicolas Girard, François-Clément Bidard, Marie-Ange Massiani, Damien Ricard, Luc Cabel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-019-0803-x |
Similar Items
-
Immune Checkpoint Inhibitor-Induced Gastroduodenitis: Recurrence after Rechallenge with Pembrolizumab
by: Catarina O’Neill, et al.
Published: (2021-04-01) -
Case Report: Longitudinal Extensive Transverse Myelitis With Novel Autoantibodies Following Two Rounds of Pembrolizumab
by: Salma Charabi, et al.
Published: (2021-04-01) -
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab
by: F.M. Perrotta, et al.
Published: (2020-11-01) -
Debilitating Skin Toxicity Associated with Pembrolizumab Therapy in an 81-Year-Old Female with Malignant Melanoma
by: Muhammad O. Khokhar, et al.
Published: (2016-12-01) -
Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date
by: McCusker MG, et al.
Published: (2020-04-01)